Related Experiment Video
Updated: Jul 14, 2026

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model
Published on: July 26, 2011
Characterization of in vivo MRI detectable thalamic amyloid plaques from APP/PS1 mice
Marc Dhenain1, Nadine El Tannir El Tayara, Ting-Di Wu
1URA CEA CNRS 2210, I2BM, SHFJ, 4 Place du Général Leclerc, 91401 Orsay Cedex, France. Marc.Dhenain@cea.fr
Abstract:
Amyloid deposits are one of the hallmarks of Alzheimer's disease. Recent studies, in transgenic mice modeling Alzheimer's disease showed that, using in vivo, contrast agent-free, MRI, thalamic amyloid plaques are more easily detected than other plaques of the brain. Our study evaluated the characteristics of these thalamic plaques in a large population of APP/PS1, PS1 and C57BL/6 mice. Thalamic spots were detected in all mice but with different frequency and magnitude. Hence, the prevalence and size of the lesions were higher in APP/PS1 mice. However, even in APP/PS1 mice, thalamic spots did not occur in all the old animals. In APP/PS1 mice, spots detection was related to high iron and calcium load within amyloid plaques and thus reflects the ability of such plaque to capture large amounts of minerals. Interestingly, calcium and iron was also detected in extra-thalamic plaques but with a lower intensity. Hypointense lesions in the thalamus were not associated with the iron load in the tissue surrounding the plaques, nor with micro-hemorrhages, inflammation, or a neurodegenerative context.
Insights
Thalamic amyloid plaques in Alzheimer's disease models are linked to high iron and calcium loads. These mineral-rich plaques are detectable via MRI, offering insights into disease progression.
Area of Science:
- Neuroscience
- Biomedical Imaging
- Alzheimer's Disease Research
Background:
- Amyloid deposits are a key feature of Alzheimer's disease (AD).
- In vivo, contrast agent-free MRI has shown potential for detecting thalamic amyloid plaques.
- Previous research suggests thalamic plaques may be more readily visualized than other brain plaques.
Purpose of the Study:
- To characterize thalamic amyloid plaques in mouse models of Alzheimer's disease.
- To investigate the relationship between mineral content and plaque detection in the thalamus.
- To compare plaque characteristics across different mouse models (APP/PS1, PS1, C57BL/6).
Main Methods:
- Utilized in vivo, contrast agent-free MRI to detect and analyze amyloid plaques.
- Examined a large population of APP/PS1, PS1, and C57BL/6 mice.
- Quantified plaque prevalence, size, and associated mineral loads (iron, calcium).
Main Results:
- Thalamic spots were detected in all mouse groups, with higher frequency and magnitude in APP/PS1 mice.
- Plaque detection in APP/PS1 mice correlated with high iron and calcium loads.
- Mineral (calcium, iron) presence was lower in extra-thalamic plaques compared to thalamic ones.
- Thalamic hypointense lesions were not linked to surrounding iron, micro-hemorrhages, inflammation, or neurodegeneration.
Conclusions:
- Thalamic amyloid plaques in AD mouse models exhibit distinct characteristics, notably high iron and calcium content.
- The mineral load within thalamic plaques influences their detectability using MRI.
- These findings highlight the thalamus as a region of interest for studying amyloid deposition and mineral interactions in Alzheimer's disease.
